Novelist John Green rails against Cepheid' TB test price; Civica Rx considers moving into chemo drugs amid shortages

Taking stock of the drug industry, from the lab to the medicine chest

September 14, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

PRNewsFoto/Cepheid via AP Novelist John Green launches attack on Cepheid over the price of its TB test John Green, a novelist and popular YouTuber, is once again leveraging his star power in the global fight to end tuberculosis. By Lizzy Lawrence and Ed Silverman STAT+ | Civica Rx considers moving into chemo drugs as shortages worsen A hospital nonprofit formed to deal with drug shortages, Civica Rx, is considering a move into chemotherapies. By John Wilkerson STAT+ | FTC warns drugmakers they can face legal action over improper patent listings Drugmakers could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry. By Ed Silverman Matt Rourke/AP Johnson & Johnson is getting rid of its script logo after more than 130 years Johnson & Johnson will replace the well-known signature script in its logo that it has used since 1887 with a modern look. By Associated Press STAT+ | Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs At issue is whether rebates ultimately discourage some people from enrolling in the Medicare Part D program. By Ed Silverman STAT+ | House subcommittee forays into fixing drug shortages A House subcommittee took a first step today toward legislation to fix drug shortages at hospitals. Don't expect a new law soon, though. By John Wilkerson Adobe STAT+ | New study adds to evidence on psychedelic as effective treatment for PTSD After 18 weeks of treatment, participants with moderate to severe PTSD who received MDMA reported significant improvements in their symptoms. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser